© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
December 05, 2021
Pharmacy leaders can be equipped to make effective decisions to support a successful work experience, regardless of work setting.
December 03, 2021
FDA approves rituximab (Rituxan) plus chemotherapy for pediatric patients with previously untreated, advanced stage, CD20-positive diffuse large B-cell lymphoma, Burkitt lymphoma, Burkitt-like lymphoma, or mature B-cell acute leukemia.
Payton Nyquvest, CEO and founder of Numinus, discussed the laboratory development and regulatory side of psychedelic research.
Ibrutinib in combination with venetoclax shows promise in patients with previously untreated chronic lymphocytic leukemia.
December 02, 2021
Affordability in drug pricing can be addressed by bringing the manufacturer and plan sponsor to negotiate costs and determine fair compensation for product and service providers in the supply chain.
December 01, 2021
The diagnostic tool widens the age group of individuals who can get tested and can be used in conjunction with a mammogram.
November 30, 2021
Approximately half of people with HCV don't know they're infected, mainly because they have no symptoms.
November 29, 2021
Although specialty therapies have the potential to help people live healthier lives, their cost and complexity can create distinct challenges.
Miglustat (Zavesca) is indicated for the treatment of mild to moderate type I Gaucher disease.
Chronic HBV increases the risk of developing liver failure, liver cancer, and cirrhosis.